<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p55" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_55{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_55{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_55{left:141px;bottom:1103px;letter-spacing:-0.1px;}
#t4_55{left:248px;bottom:1104px;letter-spacing:0.25px;}
#t5_55{left:143px;bottom:1047px;letter-spacing:-0.29px;}
#t6_55{left:250px;bottom:1067px;letter-spacing:-0.01px;}
#t7_55{left:248px;bottom:1012px;letter-spacing:0.09px;}
#t8_55{left:238px;bottom:954px;letter-spacing:-0.01px;}
#t9_55{left:238px;bottom:935px;letter-spacing:-0.01px;}
#ta_55{left:238px;bottom:915px;letter-spacing:-0.01px;}
#tb_55{left:238px;bottom:896px;letter-spacing:-0.01px;}
#tc_55{left:238px;bottom:877px;letter-spacing:-0.01px;}
#td_55{left:238px;bottom:822px;letter-spacing:-0.01px;}
#te_55{left:238px;bottom:803px;letter-spacing:-0.01px;}
#tf_55{left:238px;bottom:784px;letter-spacing:-0.01px;}
#tg_55{left:238px;bottom:764px;letter-spacing:-0.01px;}
#th_55{left:238px;bottom:745px;letter-spacing:-0.01px;}
#ti_55{left:238px;bottom:725px;letter-spacing:-0.01px;}
#tj_55{left:238px;bottom:706px;letter-spacing:-0.01px;}
#tk_55{left:238px;bottom:686px;letter-spacing:-0.01px;}
#tl_55{left:238px;bottom:667px;letter-spacing:-0.01px;}
#tm_55{left:238px;bottom:593px;letter-spacing:-0.01px;}
#tn_55{left:238px;bottom:574px;letter-spacing:-0.01px;}
#to_55{left:238px;bottom:555px;letter-spacing:-0.01px;}
#tp_55{left:458px;bottom:555px;letter-spacing:-0.01px;}
#tq_55{left:480px;bottom:555px;}
#tr_55{left:238px;bottom:500px;letter-spacing:-0.01px;}
#ts_55{left:238px;bottom:466px;letter-spacing:-0.01px;}
#tt_55{left:238px;bottom:431px;letter-spacing:-0.01px;}
#tu_55{left:238px;bottom:412px;letter-spacing:-0.01px;}
#tv_55{left:238px;bottom:392px;letter-spacing:-0.01px;}
#tw_55{left:238px;bottom:373px;letter-spacing:-0.01px;}
#tx_55{left:238px;bottom:353px;letter-spacing:-0.01px;}
#ty_55{left:238px;bottom:334px;letter-spacing:-0.01px;}
#tz_55{left:238px;bottom:314px;letter-spacing:-0.01px;}
#t10_55{left:238px;bottom:241px;letter-spacing:-0.01px;}
#t11_55{left:238px;bottom:221px;letter-spacing:-0.01px;}
#t12_55{left:238px;bottom:202px;letter-spacing:-0.01px;}
#t13_55{left:238px;bottom:182px;letter-spacing:-0.01px;}
#t14_55{left:238px;bottom:163px;letter-spacing:-0.01px;}
#t15_55{left:238px;bottom:144px;letter-spacing:-0.01px;}
#t16_55{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_55{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_55{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_55{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_55{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_55{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_55{font-size:9px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_55{font-size:13px;font-family:NotoSans-Regular_7j-;color:#F78C00;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts55" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg55Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg55" style="-webkit-user-select: none;"><object width="908" height="1286" data="55/55.svg" type="image/svg+xml" id="pdf55" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_55" class="t s0_55">7.2. Carcinomas in UICC stages I and II: cT1 cN0 and cT2 cN0 </span><span id="t2_55" class="t s1_55">55 </span>
<span id="t3_55" class="t s2_55">7.8. </span><span id="t4_55" class="t s0_55">Consensus-based recommendation </span>
<span id="t5_55" class="t s3_55">EEC </span>
<span id="t6_55" class="t s4_55">Elective neck dissection should not be performed in stage I glottic carcinoma. </span>
<span id="t7_55" class="t s5_55">Consensus: 90% </span>
<span id="t8_55" class="t s4_55">There are numerous systematic reviews and meta-analyses comparing transoral laser therapy </span>
<span id="t9_55" class="t s4_55">and primary radiotherapy for T1 and T2 vocal cord carcinoma. However, according to a </span>
<span id="ta_55" class="t s4_55">Cochrane review, only one randomized controlled trial from 1990 was found that collected </span>
<span id="tb_55" class="t s4_55">meaningful data by comparing the oncological outcomes in 234 patients with T1 and T2 </span>
<span id="tc_55" class="t s4_55">laryngeal carcinoma [165, 166]. </span>
<span id="td_55" class="t s4_55">One of the reasons for this is that planned randomized controlled trials on this issue were </span>
<span id="te_55" class="t s4_55">canceled or could not be started at all because feasibility analyses did not produce sufficient </span>
<span id="tf_55" class="t s4_55">numbers of patients [164, 174]. Hamilton et al. [175] analyzed the factors responsible for the </span>
<span id="tg_55" class="t s4_55">poor recruitment of the EaStER (Early Stage glottic cancer: Endoscopic excision or Radiotherapy) </span>
<span id="th_55" class="t s4_55">study [164]. They were able to show that not all recruiting physicians accepted the primary </span>
<span id="ti_55" class="t s4_55">outcome parameter of the study and that the inclusion criteria were not followed in some </span>
<span id="tj_55" class="t s4_55">cases. In addition, the recruiting physicians preferred the study arm with surgical therapy, </span>
<span id="tk_55" class="t s4_55">which was also reflected in the way the study information was passed on to the patients and </span>
<span id="tl_55" class="t s4_55">made randomization more difficult [175]. </span>
<span id="tm_55" class="t s4_55">In the introduction, it is stated that T1/T2 laryngeal carcinomas predominantly affect tumor </span>
<span id="tn_55" class="t s4_55">stages I and II and only need to be treated with adjuvant therapy if the criteria presented </span>
<span id="to_55" class="t s4_55">elsewhere are met (see also chapter</span><span id="tp_55" class="t s6_55">7.3 </span><span id="tq_55" class="t s4_55">). </span>
<span id="tr_55" class="t s4_55">Elective neck dissection is not indicated in stage I glottic carcinoma. </span>
<span id="ts_55" class="t s4_55">Therapy results </span>
<span id="tt_55" class="t s4_55">The 5-year overall survival after T1 vocal cord carcinoma is reported in the literature as being </span>
<span id="tu_55" class="t s4_55">74-100% [6]. An analysis of 2436 T1/T2 vocal cord carcinomas treated transorally showed a 5- </span>
<span id="tv_55" class="t s4_55">year overall survival of 82% [172]. With regard to overall survival, cohort studies on T1 laryngeal </span>
<span id="tw_55" class="t s4_55">carcinoma showed no difference between surgical and radiotherapeutic approaches [173]. A </span>
<span id="tx_55" class="t s4_55">systematic review of case series and non-controlled studies from 2012 could not demonstrate </span>
<span id="ty_55" class="t s4_55">any differences in overall survival between endolaryngeal surgery and radiotherapy when </span>
<span id="tz_55" class="t s4_55">analyzing a total of 17 studies [167]. </span>
<span id="t10_55" class="t s4_55">There are meta-analyses of observational studies comparing overall survival in patients with </span>
<span id="t11_55" class="t s4_55">T1 and T2 vocal cord carcinomas after transoral laser surgery and radiotherapy [168]. One </span>
<span id="t12_55" class="t s4_55">meta-analysis of observational studies showed a significantly better overall survival after </span>
<span id="t13_55" class="t s4_55">laser therapy for T1 and T2 vocal cord carcinomas [168], the other two meta-analyses [169, </span>
<span id="t14_55" class="t s4_55">176], in which only T1 or T1a vocal cord carcinomas were evaluated, also showed a better </span>
<span id="t15_55" class="t s4_55">survival after laser therapy, the </span>
<span id="t16_55" class="t s0_55">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
